We know what it’s like to raise capital as a founder, and often the opaque focus of investors can make targeting or curating investors tricky. That’s why we’ve published our Humanity Scale Healthcare Thesis — so it’s clear about what we're on the lookout to invest in. We are on a mission to fund high impact medtech, healthtech and biotech research based startups that will decrease mortality and improve quality of life for millions of humans. Based on our domain expertise, we’re honing in on sectors like women’s health and femtech, ageing, autoimmune diseases, neurotech, as well as preventative and disruptive treatments. To help us reach humanity-scale healthcare, we’re already proud backers of our portcos including Coviu Global, Pending AI, Prospection, Inventia Life Science, Psylo and Cylite. Read the full blog for more on the ideas that excite us, and how we can help scale your vision. #DeepTech #HealthTech
Main Sequence
Venture Capital and Private Equity Principals
Eveleigh, NSW 11,781 followers
Australia’s deep tech investment fund tackling the world’s biggest challenges
About us
We are Australia’s deep tech investment fund tackling the world’s biggest challenges by turning today’s scientific discoveries into tomorrow’s industries. Main Sequence works closely with scientists, researchers and industry collaborators to create, fund and accelerate new companies and industries that accelerate humanity for a more prosperous future. Main Sequence was set up in 2017 to manage the CSIRO Innovation Fund, founded by the Australian Government and the national science agency to reinvest its historic contributions into the successes of the future. Over the past four years, Main Sequence has invested in 39 companies changing the way healthcare is delivered, food is produced, spaces are connected and more. These investments have led to more than 60 company collaborative projects with universities and 19 projects with CSIRO.
- Website
-
http://www.mseq.vc
External link for Main Sequence
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- Eveleigh, NSW
- Type
- Partnership
- Founded
- 2016
- Specialties
- Deep tech, Innovation, Venture capital, and Startups
Locations
-
Primary
Level 5, 13 Garden St
Eveleigh, NSW 2015, AU
Employees at Main Sequence
Updates
-
Sneak peak into the lab of one of our portcos, Endua. 👀 Endua is Australia’s leading company developing advanced hydrogen electrolysis technologies. After three years of learning and research and development with CSIRO, Endua’s V2 Hydrogen PEM Electrolyser is a plug and play, power-to-gas solution designed for on-site generation of hydrogen. This is game-changing because the on-site production of hydrogen removes the challenges associated with transportation and bulk storage of hydrogen and protects against supply chain disruption. Expected to progress from prototype to production in 2025, Endua is imagining the renewable energy of the future. Watch this space! #DeepTech #Renewables
-
Last week, Ed Husic MP headed to Orange to visit one of our portcos, Cauldron Ferm, and tour its novel 25,000-litre demo facility. 🌏 Cauldron Ferm has recently been celebrated as a recipient of the government’s Industry Growth Program grant, which helps startups as they commercialise and scale their ideas. Cauldron’s passion for biomanufacturing is fuelled by over three decades of continuous R&D and 10 years of hands-on experience in hyper-fermentation manufacturing. We’re proud to support the Cauldron Ferm as it charts the path for a brighter future for the biotech industry. #FutureMadeInAustralia #DeepTech
-
BluGlass Limited (ASX: BLG) has teamed up with the Semiconductor Sector Service Bureau (S3B) and ShareCafe to host the Semiconductor Australia Conference 2024 on 24 October. ✨ This one-day event in Sydney will spotlight some of Australia’s brightest innovators in the semiconductor, quantum, and photonics sectors. Mark Luo, CEO & Co-Founder at Quantum Brilliance, one of our portfolio companies, will be speaking at a panel about Australia's role in the quantum future. Our Partner, Mike Nicholls, is also running a semiconductor pitch competition for new startups in the sectors with local and international investors on the panel. Reach out to Mike to register your startup. Interested in participating in the conference? Find more details in the comments below.
-
One of the key focus areas at Main Sequence is investing in companies working towards building an equitable, quality healthcare system. 🌏 That’s why we’re proud to sponsor the Future Leader Award, as part of NSW Medical Research’s Commercialisation Training Program. The program helps to fast track novel medical devices, diagnostic/ therapeutic products and digital health solutions into the market. Last week, a ceremony was held for graduates of the program, with award winners, ShanShan Wang, Danielle Fisher GAICD, and Veysel Kayser being celebrated for their contributions. #HealthTech #Startups #DeepTech
-
Quantum Brilliance has secured a strategic partnership with ParityQC to develop the world’s 1st mobile quantum computer by 2027. 💻 Quantum Brilliance continues to set itself apart from it’s global counterparts, with their cutting-edge technology thats paving the way for for defence, cybersecurity, and beyond. To read more about this project from Agentur für Innovation in der Cybersicherheit GmbH (Cyberagentur), check out the link in the comments. 👇 #QuantumComputing #TechInnovation #DeepTech
-
What is AI? Depending on who you ask, you will get a different answer. Danielle Haj-Moussa recently spoke with AI Australia Podcast about the importance of upskilling in #ArtificialItelligence. To find out more on why AI #upskilling is important for venture capital and beyond, listen to full episode in the comments below. 👇
-
Last week, our very own Phil Morle and Mike Nicholls spent an incredible week with our VC community in Darwin at Innovation Bay’s Explore24 and Venture Downunder. It was a great opportunity for everyone to step back, embrace new experiences, and engage in insightful discussions with one another. Phil sat down with NT local entrepreneur Liandra Gaykamangu from Liandra Swim, where they discussed how Indigenous entrepreneurs build valuable companies that positively impact both people and the planet. A big shoutout to the Innovation Bay team for organising such an amazing event that brings our community together! 🏖️ #IBExplore24 #IBVDU24
-
Catch Danielle Haj-Moussa at Cicada Innovations’ 2-day workshop, Deep Tech Elevate. 🎤 Our Investment Associate, Danielle will share her insights on how she’s helping mentor startups to scale and commercialise while also tackling some of the world’s toughest challenges. Register to expand your network and hear from Danielle through the link in the comments.👇
-
As an existing investor in Number 8 bio, we’re excited to lead their latest $7 million Seed round, with support from Breakthrough Victoria and The March Group. 🥂 These funds will be used to advance product development, scale up a manufacturing facility, and establish key commercial partnerships, all aimed at tackling methane emissions from livestock. We’re proud to continue supporting SynBio companies like Number 8 Bio in their mission to decarbonise our planet while helping farmers achieve a strong return on investment. 🌱 Learn more in the comment below. #SynBio